Rainbow Children's Medicare Limited share price
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments,…Read more
- Market Cap₹ 12,634 Cr.
- Current Price₹ 1,248.90
- High / Low₹ 1,610 / 1,084
- Stock P/E44.4
- Book Value₹ 162
- Dividend Yield0.28 %
- ROCE16.8 %
- ROE17.90 %
- Face Value₹ 10.0
More figures (10)
- EPS (TTM)₹ 28.11
- Price / Book7.69
- OPM23.7 %
- Debt / Equity0.54
- Sales growth (3Y)13.2 %
- Profit growth (3Y)9.9 %
- Promoter holding52.3 %
- EV / EBITDA22.4
- Beta0.15
- All-time high₹ 1,710
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| RAINBOW | -14.29% | -16.23% | -0.64% | -5.39% | -5.17% | +5.62% | — |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- Rainbow Children's Medicare Limited is in the Medical Care Facilities industry (Healthcare), with a market value of ₹12,634 crore.
- It trades at 44.4 times its last 12 months' earnings and 7.7 times book value.
- Revenue grew 13.2% a year over the last 3 years, profit 9.9% a year.
- Return on equity was 17.9% and return on capital employed 16.8% in the latest year.
- Debt was 0.54 times shareholders' equity.
- The share price is 22.4% below its 52-week high and down 5.2% over one year.
- Promoters and insiders hold about 52.3%; institutions about 33.8%.
Pros
AI- Strong return on equity: 18.2% on average over the last 3 years.
- Latest quarter (Jun 2026): sales up 33% and profit up 16% from a year ago.
- Trades at 44.4 times earnings, below its 3-year median of 57.0.
Cons
AINo standout weaknesses in the reported figures.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About Rainbow Children's Medicare Limited
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children'…
- Employees
- 4,724
- Head office
- Hyderabad
- NSE industry
- Healthcare
Peer comparison
HealthcareHealthcareMedical Care Facilities
Part ofNifty 500Nifty Smallcap 250
| S.No. | Company | CMP ₹ | P/E | Mar Cap ₹ Cr | Div Yld % | NP Qtr ₹ Cr | Qtr Profit Var % | Sales Qtr ₹ Cr | Qtr Sales Var % | ROCE % | ROE % | P/B | OPM % | Debt / Eq | Prom. Hold. % | Sales ₹ Cr | Sales Var 3Yrs % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Rainbow Children's Medicare | 1,248.90 | 44.4 | 12,634 | 0.28 | 63 | 16.23 | 470 | 33.17 | 16.8 | 17.9 | 7.69 | 23.7 | 0.54 | 52.29 | 1,703 | 13.2 |
| 2. | Apollo Hospitals Enterprise | 7,890.00 | 54.3 | 1,13,446 | 0.25 | 581 | 49.05 | 7,044 | 25.95 | 19.2 | 21.9 | 11.97 | 11.7 | 0.90 | 28.39 | 24,911 | 14.8 |
| 3. | Max Healthcare Institute | 846.00 | 56.7 | 82,342 | 0.23 | 323 | 4.87 | 2,366 | 16.70 | 12.6 | 14.3 | 7.66 | 22.8 | 0.32 | 28.20 | 8,225 | 22.4 |
| 4. | Aster DM Quality Care | 674.35 | 109.3 | 58,781 | 0.44 | 29 | -68.70 | 1,311 | 21.60 | 9.4 | 9.7 | 7.59 | 14.2 | 0.49 | 64.26 | 4,643 | 15.7 |
| 5. | Fortis Healthcare | 736.50 | 53.1 | 55,603 | 0.13 | 266 | 2.35 | 2,545 | 17.46 | 11.9 | 11.1 | 5.62 | 17.8 | 0.35 | 35.19 | 9,048 | 13.3 |
| 6. | Narayana Hrudayalaya | 1,719.40 | 42.5 | 34,921 | 0.26 | 207 | 5.35 | 2,684 | 78.05 | 11.4 | 19.7 | 7.70 | 15.5 | 1.29 | 67.23 | 7,858 | 20.5 |
| 7. | Global Health | 1,240.00 | 60.0 | 33,322 | 0.04 | 159 | -0.18 | 1,304 | 26.50 | 15.0 | 15.1 | 8.41 | 16.8 | 0.30 | 66.39 | 4,318 | 17.2 |
| 8. | Krishna Institute of Medical Sciences | 685.60 | 134.4 | 28,796 | 0.00 | 42 | -47.20 | 1,180 | 35.33 | 8.1 | 11.0 | 12.21 | 13.8 | 1.89 | 41.74 | 3,872 | 21.3 |
| 9. | Nephrocare Health Services | 614.35 | 72.4 | 6,178 | 0.00 | 32 | — | 282 | — | 13.3 | 9.0 | 5.52 | 14.0 | 0.07 | 49.30 | 999 | 33.9 |
| 10. | Jeena Sikho Lifecare | 388.30 | 20.5 | 4,828 | 1.16 | 66 | 28.57 | 224 | 28.76 | 54.5 | 61.3 | 10.34 | 38.2 | 0.27 | 72.48 | 799 | 57.7 |
| Median: 11 Co. | 791.25 | 54.3 | 33,322 | 0.23 | 112 | 4.87 | 1,307 | 26.50 | 13.0 | 15.1 | 7.70 | 16.8 | 0.42 | 50.80 | 4,481 | 20.5 |
Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.
Quarterly Results
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Projection — your assumptions
Starts from the last four reported quarters (TTM) and applies the figures you enter; growth is pre-filled with the company's own 3-year sales growth. This is a what-if calculator for illustration, not a forecast, estimate or recommendation.
Related party transactions
Related-party transactions are dealings with promoters, directors, subsidiaries and associates. Companies disclose them to the exchanges every half-year and in detail in the notes to their annual report.
- Related Party TransactionsRainbow Childrens Medicare Limited has informed the Exchange about related Party Transactions14-May-2023
- Related Party TransactionPlease find the enclosed herewith Related Party Transactions of the Company for the half year ended September 30, 2022.17-Nov-2022
- Related Party TransactionPlease find the enclosed herewith Related Party Transactions of the Company for the half year ended March 31, 2022.09-Jun-2022
Full details: notes to the Financial Year 2026 annual report (related party disclosures).
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| 974 | 1,174 | 1,297 | 1,516 | 1,703 | 1,820 | |
| YOY Sales Growth % | 20.52% | 10.51% | 16.88% | 12.35% | ||
| 669 | 777 | 868 | 1,026 | 1,159 | 1,245 | |
| Material Cost % | 20% | 13% | 13% | 13% | 13% | 13% |
| Employee Cost % | 12% | 12% | 14% | 14% | 14% | 14% |
| Other Expenses % | 37% | 40% | 41% | 41% | 41% | 41% |
| Operating Profit | 305 | 396 | 429 | 490 | 544 | 575 |
| OPM % | 31% | 34% | 33% | 32% | 32% | 32% |
| 19 | 31 | 37 | 51 | 44 | 36 | |
| Exceptional items | -2 | -2 | ||||
| Interest | 53 | 55 | 59 | 72 | 78 | 81 |
| Depreciation | 83 | 90 | 112 | 138 | 151 | 159 |
| Profit before tax | 187 | 282 | 295 | 330 | 358 | 371 |
| 26% | 25% | 26% | 26% | 21% | 22% | |
| Current tax | 58 | 84 | 77 | 89 | 96 | |
| Deferred tax | -9 | -15 | -1 | -4 | -19 | |
| 139 | 212 | 218 | 244 | 282 | 290 | |
| Minority share | 0 | 2 | 1 | 1 | 3 | 5 |
| Profit to shareholders | 138 | 211 | 217 | 243 | 278 | 285 |
| YOY Profit Growth % | 53.15% | 2.78% | 11.88% | 15.28% | ||
| EPS in Rs | 14.75 | 20.89 | 21.38 | 23.97 | 27.41 | 28.11 |
| Dividend Payout % | 10% | 14% | 13% | 11% |
Compounded Sales Growth
- 3 Years:
- 13%
- TTM:
- 18%
Compounded Profit Growth
- 3 Years:
- 10%
- TTM:
- 12%
Stock Price CAGR
- 3 Years:
- 6%
- 1 Year:
- -5%
Return on Equity
- 4 Years:
- 19%
- Last Year:
- 18%
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| 925 | 1,114 | 1,237 | 1,455 | 1,546 | 1,621 | |
| YOY Sales Growth % | 20.48% | 11.00% | 17.63% | 6.27% | ||
| 629 | 732 | 823 | 980 | 1,046 | 1,106 | |
| Material Cost % | 20% | 13% | 13% | 13% | 13% | 13% |
| Employee Cost % | 12% | 12% | 14% | 14% | 14% | 14% |
| Other Expenses % | 36% | 40% | 40% | 41% | 41% | 42% |
| Operating Profit | 296 | 382 | 413 | 474 | 500 | 515 |
| OPM % | 32% | 34% | 33% | 33% | 32% | 32% |
| 21 | 31 | 37 | 49 | 43 | 37 | |
| Exceptional items | -5 | -2 | -2 | |||
| Interest | 50 | 52 | 56 | 70 | 71 | 73 |
| Depreciation | 77 | 84 | 105 | 132 | 136 | 141 |
| Profit before tax | 190 | 273 | 289 | 322 | 334 | 336 |
| 25% | 25% | 26% | 26% | 25% | 25% | |
| Current tax | 58 | 81 | 75 | 88 | 91 | |
| Deferred tax | -10 | -14 | -0 | -3 | -7 | |
| 142 | 206 | 215 | 238 | 250 | 251 | |
| YOY Profit Growth % | 44.70% | 4.37% | 10.56% | 5.23% | ||
| EPS in Rs | 15.18 | 20.40 | 21.17 | 23.40 | 24.62 | 24.73 |
| Dividend Payout % | 10% | 14% | 13% | 12% |
Compounded Sales Growth
- 3 Years:
- 12%
- TTM:
- 10%
Compounded Profit Growth
- 3 Years:
- 7%
- TTM:
- 0%
Stock Price CAGR
- 3 Years:
- 6%
- 1 Year:
- -5%
Return on Equity
- 4 Years:
- 19%
- Last Year:
- 18%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 102 | 102 | 102 | 102 |
| Reserves | 958 | 1,157 | 1,367 | 1,547 |
| Borrowings | 570 | 765 | 764 | 891 |
| 140 | 146 | 145 | 236 | |
| Trade payables | 79 | 81 | 84 | 101 |
| Minority interest | 5 | 6 | 7 | 16 |
| Current liabilities | 139 | 149 | 151 | 187 |
| Total Liabilities | 1,771 | 2,170 | 2,377 | 2,775 |
| 976 | 1,433 | 1,439 | 1,673 | |
| Gross block | 1,358 | 1,927 | 2,069 | 2,445 |
| Accumulated depreciation | 382 | 494 | 630 | 771 |
| Goodwill & intangibles | 5 | 10 | 11 | 198 |
| CWIP | 48 | 184 | 51 | 112 |
| 747 | 554 | 887 | 990 | |
| Inventories | 19 | 24 | 28 | 42 |
| Trade receivables | 63 | 75 | 79 | 100 |
| Cash & equivalents | 17 | 10 | 20 | 34 |
| Current assets | 478 | 622 | 822 | 663 |
| Total Assets | 1,771 | 2,170 | 2,377 | 2,775 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 329 | 321 | 396 | 420 | |
| Profit for the year | 211 | 217 | 243 | 278 |
| Working capital changes | 4 | -25 | -9 | -30 |
| Direct taxes paid | -81 | -89 | -86 | -102 |
| -465 | -226 | -268 | -259 | |
| Fixed assets purchased | -141 | -354 | -146 | -216 |
| Fixed assets sold | 0 | 0 | 0 | 1 |
| Investments purchased | -432 | -1,046 | -992 | -925 |
| Investments sold | 82 | 1,136 | 847 | 1,073 |
| 143 | -102 | -118 | -147 | |
| Repayment of borrowings | -40 | |||
| Interest paid | -3 | -72 | -78 | |
| Dividends paid | -20 | -31 | -30 | -30 |
| Net Cash Flow | 7 | -7 | 10 | 14 |
| Free Cash Flow | 187 | -32 | 250 | 203 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROE | — | 19.9% | 18.7% | 17.9% | 17.9% |
| ROCE | — | 20.6% | 17.5% | 18.1% | 16.8% |
| Operating margin | — | 27.1% | 25.2% | 23.8% | 23.7% |
| Net margin | — | 18.2% | 16.9% | 16.3% | 16.6% |
| Debt / equity | — | 0.54 | 0.61 | 0.52 | 0.54 |
| Current ratio | — | 3.44 | 4.16 | 5.46 | 3.55 |
| Debtor days | — | 20 | 21 | 19 | 22 |
| Inventory days | — | 43 | 53 | 52 | 67 |
| Days payable | — | 182 | 180 | 158 | 162 |
| Cash conversion cycle | — | -119 | -106 | -87 | -73 |
| Working capital days | — | 107 | 134 | 164 | 104 |
Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 49.83%
- FIIs 14.66%
- DIIs 23.28%
- Public 11.83%
| % | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.83% | 49.83% | 49.88% | 49.85% | 49.85% | 49.85% | 49.85% | 49.85% | 49.84% | 49.84% | 49.84% | 49.83% |
| 22.32% | 24.04% | 24.78% | 25.11% | 25.12% | 23.69% | 23.59% | 21.85% | 19.23% | 17.24% | 16.03% | 14.66% | |
| Foreign portfolio investors (Cat. I) | 21.95% | 23.58% | 24.35% | 24.70% | 24.66% | 23.08% | 22.96% | 20.90% | 18.42% | 16.61% | 15.45% | 14.07% |
| Foreign portfolio investors (Cat. II) | 0.37% | 0.46% | 0.43% | 0.42% | 0.46% | 0.61% | 0.64% | 0.95% | 0.82% | 0.63% | 0.58% | 0.59% |
| 15.62% | 14.76% | 13.80% | 13.83% | 13.87% | 15.31% | 15.44% | 17.46% | 19.49% | 21.13% | 22.56% | 23.28% | |
| Mutual funds | 11.19% | 10.54% | 9.80% | 9.71% | 10.11% | 11.47% | 11.28% | 12.99% | 15.49% | 17.46% | 18.53% | 18.84% |
| Insurance companies | 1.97% | 1.95% | 1.88% | 1.92% | 1.66% | 1.71% | 2.00% | 2.25% | 2.29% | 1.97% | 2.68% | 2.76% |
| Alternative investment funds | 2.46% | 2.27% | 2.13% | 2.21% | 2.10% | 2.13% | 2.16% | 2.22% | 1.71% | 1.69% | 1.35% | 1.68% |
| 12.23% | 11.37% | 11.54% | 11.20% | 11.16% | 11.14% | 11.11% | 10.84% | 11.40% | 11.67% | 11.39% | 11.83% | |
| Retail (up to ₹2 lakh) | 5.29% | 4.70% | 5.04% | 4.96% | 4.96% | 4.94% | 5.00% | 4.81% | 5.32% | 5.42% | 5.13% | 5.53% |
| HNIs (above ₹2 lakh) | 5.74% | 5.70% | 5.69% | 5.44% | 5.42% | 5.40% | 5.32% | 5.24% | 5.18% | 5.28% | 5.28% | 5.21% |
| NRIs | 0.36% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.24% | 0.20% | 0.24% | 0.27% | 0.26% | 0.29% |
| Bodies corporate | 0.73% | 0.65% | 0.46% | 0.42% | 0.43% | 0.45% | 0.43% | 0.46% | 0.54% | 0.57% | 0.60% | 0.63% |
| No. of Shareholders | 80,471 | 77,152 | 78,557 | 77,524 | 78,764 | 79,092 | 80,320 | 81,134 | 88,809 | 88,561 | 89,305 | 92,814 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Mutual funds & institutions holding Rainbow Children's Medicare
| Holder (above 1%) | Stake |
|---|---|
| ICICI Prudential Healthcare FundMutual fund | 5.50% |
| DSP Flexi Cap FundMutual fund | 3.42% |
| Hdfc Life Insurance Company LimitedInsurance | 2.10% |
| Titanium Equity Long-Short FundMutual fund | 1.88% |
| Nippon Life India Trustee Ltd- A/C Nippon India ViMutual fund | 1.63% |
| AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FMutual fund · see the fund house | 1.57% |
| Motilal Oswal Nifty Smallcap 250 Index FundMutual fund | 1.51% |
As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 18.84% of the company. Shareholders below 1% are not named in the filing.
Documents
Announcements
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Rainbow Childrens Medicare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 201807-Oct-2026
- UpdatesRainbow Childrens Medicare Limited has informed the Exchange regarding 'execution of lease agreement with APCRDA for development of a children s hospital at Amravati, Andhra Prade…30-Sep-2026
- Trading WindowRainbow Childrens Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201525-Sep-2026
- AppointmentRainbow Childrens Medicare Limited has informed the Exchange regarding Appointment of Mr Sudarshan Patodia as Chief Financial Officer of the company w.e.f. September 23, 2026.23-Sep-2026
- Options to purchase securitiesRainbow Childrens Medicare Limited has informed the Exchange about the grant of options23-Sep-2026
- UpdatesRainbow Childrens Medicare Limited has informed the Exchange regarding 'Intimation of Contact Details of Key Managerial Personnel authorised under Regulation 30(5) of SEBI (LODR) …23-Sep-2026
- Outcome of Board MeetingRainbow Childrens Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on September 23, 2026.23-Sep-2026
- General UpdatesRAINBOW: Rainbow Children's Medicare Limited has informed the Exchange about Commencement of operations at Guntur, Andhra Pradesh.16-Sep-2026
- Resignation of Director/KMP/SMPRainbow Childrens Medicare Limited has informed the Exchange about Resignation of Director/KMP/SMP31-Aug-2026
- ResignationRAINBOW: Rainbow Children's Medicare Limited has informed the Exchange regarding Resignation of Mr. Srinath Metla as Senior Management Personnel of the company w.e.f. September 05…31-Aug-2026
- Resignation of Director/KMP/SMPRainbow Childrens Medicare Limited has informed the Exchange about Resignation of Director/KMP/SMP25-Aug-2026
- ResignationRainbow Childrens Medicare Limited has informed the Exchange regarding Resignation of Mr Vikas Maheshwari as Chief Financial Officer of the company w.e.f. August 31, 2026.25-Aug-2026
Annual reports
- Financial Year 202606-JUL-2026
- Financial Year 202513-JUN-2025
- Financial Year 202408-JUL-2024
- Financial Year 2023
- Financial Year 2022
Credit ratings
- Credit RatingRainbow Childrens Medicare Limited has informed the Exchange about Credit Rating29-Sep-2026
- Credit RatingRainbow Childrens Medicare Limited has informed the Exchange about Credit Rating14-Aug-2025
- Credit Rating- OthersRainbow Childrens Medicare Limited has informed the Exchange about Credit Rating- Others07-Jan-2025
Concalls & investor meets
- Analysts/Institutional Investor Meet/Con. Call UpdatesRainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet of Analyst/Institutional Investors Group Meetings.11-Sep-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesRainbow Childrens Medicare Limited has informed the Exchange about Transcript04-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesRainbow Childrens Medicare Limited has informed the Exchange about Link of Recording31-Jul-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesRainbow Childrens Medicare Limited has informed the Exchange about Presentation30-Jul-2026
- Investor PresentationRainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation30-Jul-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesRainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet23-Jul-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesRainbow Childrens Medicare Limited has informed the Exchange about Transcript01-Jun-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesRainbow Childrens Medicare Limited has informed the Exchange about Link of Recording25-May-2026
- Investor PresentationRainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation23-May-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesRainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet15-May-2026
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 21 Jul 2026
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Latest news
In the news
No recent coverage found.
From the company (NSE)
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Rainbow Childrens Medicare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018NSE filing · 07-Oct-2026
- UpdatesRainbow Childrens Medicare Limited has informed the Exchange regarding 'execution of lease agreement with APCRDA for development of a children s hospital at Amravati, Andhra Prade…NSE filing · 30-Sep-2026
- Trading WindowRainbow Childrens Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015NSE filing · 25-Sep-2026
- AppointmentRainbow Childrens Medicare Limited has informed the Exchange regarding Appointment of Mr Sudarshan Patodia as Chief Financial Officer of the company w.e.f. September 23, 2026.NSE filing · 23-Sep-2026
- Options to purchase securitiesRainbow Childrens Medicare Limited has informed the Exchange about the grant of optionsNSE filing · 23-Sep-2026
- UpdatesRainbow Childrens Medicare Limited has informed the Exchange regarding 'Intimation of Contact Details of Key Managerial Personnel authorised under Regulation 30(5) of SEBI (LODR) …NSE filing · 23-Sep-2026
- Outcome of Board MeetingRainbow Childrens Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on September 23, 2026.NSE filing · 23-Sep-2026
- General UpdatesRAINBOW: Rainbow Children's Medicare Limited has informed the Exchange about Commencement of operations at Guntur, Andhra Pradesh.NSE filing · 16-Sep-2026
Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.
Questions about Rainbow Children's Medicare Limited
What is the share price of Rainbow Children's Medicare Limited today?
What is the market cap of Rainbow Children's Medicare Limited?
What is the P/E ratio of Rainbow Children's Medicare Limited?
Is Rainbow Children's Medicare Limited a good investment?
How can I buy Rainbow Children's Medicare Limited shares?
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.
